scispace - formally typeset
Book ChapterDOI

CCL2 in the Tumor Microenvironment

Reads0
Chats0
TLDR
The C-C motif chemokine ligand 2 (CCL2) is a crucial mediator of immune cell recruitment during microbial infections and tissue damage as discussed by the authors and plays a role in recruiting tumor-associated macrophages (TAMs), which adopt a pro-tumorigenic phenotype and support cancer cell survival, facilitate tumor cell invasion, and promote angiogenesis.
Abstract
The C-C motif chemokine ligand 2 (CCL2) is a crucial mediator of immune cell recruitment during microbial infections and tissue damage. CCL2 is also frequently overexpressed in cancer cells and other cells in the tumor microenvironment, and a large body of evidence indicates that high CCL2 levels are associated with more aggressive malignancies, a higher probability of metastasis, and poorer outcomes in a wide range of cancers. CCL2 plays a role in recruiting tumor-associated macrophages (TAMs), which adopt a pro-tumorigenic phenotype and support cancer cell survival, facilitate tumor cell invasion, and promote angiogenesis. CCL2 also has direct, TAM-independent effects on tumor cells and the tumor microenvironment, including recruitment of other myeloid subsets and non-myeloid cells, maintaining an immunosuppressive environment, stimulating tumor cell growth and motility, and promoting angiogenesis. CCL2 also plays important roles in the metastatic cascade, such as creating a pre-metastatic niche in distant organs and promoting tumor cell extravasation across endothelia. Due to its many roles in tumorigenesis and metastatic processes, the CCL2-CCR2 signaling axis is currently being pursued as a potential therapeutic target for cancer.

read more

Citations
More filters
Journal ArticleDOI

Chemokines and Cytokines: Axis and Allies in Prostate Cancer Pathogenesis.

TL;DR: In this article , a review of the alteration of chemokine and cytokine profiles during prostate cancer progression and metastasis was made, which revealed that chemokines and cytokines are responsible for the pleiotropic actions in cancer, including the growth, angiogenesis, endothelial mesenchymal transition, leukocyte infiltration, and hormone escape for advanced prostate cancer.
Journal ArticleDOI

Role of chemokine systems in cancer and inflammatory diseases

Hongyi Li, +2 more
- 01 Jun 2022 - 
TL;DR: Recent advances of chemokine systems in protumor and antitumor immune responses are summarized and the prevailing understanding of how the chemokines system operates in inflammatory diseases is discussed.
Journal ArticleDOI

A timeline of tumour-associated macrophage biology

TL;DR: Cassetta and Pollard as discussed by the authors chronologically explore the evolution of TAM biology put into the context of major enabling advances in macrophage biology and conclude that TAMs will be a major target for therapeutic intervention.
Journal ArticleDOI

Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment

TL;DR: Eithelial SOX9 is critical in suppressing CD8+ T cell responses and modified macrophage function in GAC through the paracrine LIF factor, and Cotargeting LIF/LIFR and CSF1R has great potential in targetingSOX9-mediated cancer stemness, T cell immunosuppression and metastases suggesting the novel combination therapy against advanced GAC.
Journal ArticleDOI

Development of an Anti-human CCR2 Monoclonal Antibody (C2Mab-9) by N-Terminal Peptide Immunization.

TL;DR: Flow cytometric and immunocytochemical results showed that C2Mab-9 reacted with hCCR2-expressing U937 (human histiocytic lymphoma) and natural killer cells, and showed the moderate binding affinity for both cells, indicating that C1MAb-9 can be a useful tool for analyzing hCCr2-related biological responses.
References
More filters
Journal ArticleDOI

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

TL;DR: It is demonstrated that bone-marrow-derived human mesenchymal stem cells, when mixed with otherwise weakly metastatic human breast carcinoma cells, cause the cancer cells to increase their metastatic potency greatly when this cell mixture is introduced into a subcutaneous site and allowed to form a tumour xenograft.
Journal ArticleDOI

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

TL;DR: The mechanistic link between CCL2 expression and macrophage infiltration are correlated with poor prognosis and metastatic disease in human breast cancer and the origin of these macrophages is defined by showing that Gr1-positive inflammatory monocytes are preferentially recruited to pulmonary metastases but not to primary mammary tumours in mice.
Journal ArticleDOI

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.

TL;DR: The results suggest that the T- Tropic viruses characteristic of disease progression may evolve from purely M-tropic viruses prevalent early in virus infection through changes in the env protein that enable the virus to use multiple entry cofactors.
Journal ArticleDOI

MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis

TL;DR: The matrix metalloproteinase MMP-9/gelatinase B is upregulated in angiogenic dysplasias and invasive cancers of the epidermis in a mouse model of multi-stage tumorigenesis elicited by HPV16 oncogenes, suggesting inflammatory cells can be coconspirators in carcinogenesis.
Journal Article

Association of Macrophage Infiltration with Angiogenesis and Prognosis in Invasive Breast Carcinoma

TL;DR: Analysis of macrophage infiltration in invasive breast carcinomas indicates a role for macrophages in angiogenesis and prognosis in breast cancer and that this cell type may represent an important target for immunoinhibitory therapy in Breast cancer.
Related Papers (5)
Trending Questions (1)
Whats the difference between CXCL2 and CCL2

CXCL2 and CCL2 are distinct chemokines; CCL2 mediates immune cell recruitment in infections and cancer, while CXCL2 is not discussed in the paper.